trastuzumab deruxtecan
daiichi sankyo,astrazeneca
['pan-tumor', 'pantumor', 'determination', 't-dxd', 'arca ', 'arca, (-arcade)']
targeting #her-2 in #biliary (3/3 from #asco23) #t-dxd pantumor study (destiny-pantumor02) -41 btc (16 ihc 3 +) orr 56% (ihc 3+ btc), dor 11m (pan-tumor), mpfs not reported ihc determination of her-2 
HPB and NET Medical Oncologist at @Hospital_FJD. Chair of @myESMO Media and Press Affairs WG. Chair of @EORTC Hepato-Biliary TF. #BiliaryCancer #HCC #NET #PDAC